| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | RASSF2 RPS6KA1 RPS6KB1 RPS6KB2 SRMS MAP3K4 PRKD3 PTK2B EGFR MTOR PKN1 MST1L FGR MAPK7 MAP2K5 | 6.41e-07 | 600 | 106 | 15 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | RASSF2 RPS6KA1 RPS6KB1 RPS6KB2 SRMS DGKH MAP3K4 PRKD3 PTK2B EGFR MTOR PKN1 MST1L FGR MAPK7 MAP2K5 | 1.01e-06 | 709 | 106 | 16 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | RASSF2 RPS6KA1 RPS6KB1 RPS6KB2 SRMS DGKH MAP3K4 PRKD3 PTK2B EGFR MTOR GYS1 GYS2 PKN1 MST1L FGR MAPK7 MAP2K5 | 2.04e-06 | 938 | 106 | 18 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | RASSF2 RPS6KA1 RPS6KB1 RPS6KB2 SRMS DGKH MAP3K4 PRKD3 PTK2B EGFR MTOR PKN1 MST1L FGR MAPK7 MAP2K5 | 2.67e-06 | 764 | 106 | 16 | GO:0016301 |
| GeneOntologyMolecularFunction | ribosomal protein S6 kinase activity | 5.01e-06 | 7 | 106 | 3 | GO:0004711 | |
| GeneOntologyMolecularFunction | epoxide hydrolase activity | 2.33e-05 | 11 | 106 | 3 | GO:0004301 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | RPS6KA1 RPS6KB1 RPS6KB2 MAP3K4 PRKD3 PTK2B EGFR MTOR PKN1 MAPK7 MAP2K5 | 2.52e-05 | 446 | 106 | 11 | GO:0004674 |
| GeneOntologyMolecularFunction | glutamate decarboxylase activity | 2.79e-05 | 2 | 106 | 2 | GO:0004351 | |
| GeneOntologyMolecularFunction | glycogen synthase activity, transferring glucose-1-phosphate | 2.79e-05 | 2 | 106 | 2 | GO:0061547 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ether bonds | 4.00e-05 | 13 | 106 | 3 | GO:0016801 | |
| GeneOntologyMolecularFunction | ether hydrolase activity | 4.00e-05 | 13 | 106 | 3 | GO:0016803 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity | 8.35e-05 | 3 | 106 | 2 | GO:0004373 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.34e-04 | 211 | 106 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.37e-04 | 363 | 106 | 9 | GO:0106310 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 4.32e-04 | 28 | 106 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | kinase binding | ACACA PTPN22 DGKH JAKMIP2 PTK2B TRAF4 EGFR MTOR TAX1BP1 PKN1 MST1L PLCG1 FGR MAPK7 | 6.03e-04 | 969 | 106 | 14 | GO:0019900 |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 8.41e-04 | 35 | 106 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 8.72e-04 | 288 | 106 | 7 | GO:0016757 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.06e-03 | 145 | 106 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.35e-03 | 153 | 106 | 5 | GO:0008194 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.74e-03 | 239 | 106 | 6 | GO:0031406 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 1.87e-03 | 46 | 106 | 3 | GO:0004715 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 1.99e-03 | 47 | 106 | 3 | GO:0004712 | |
| GeneOntologyMolecularFunction | UDP-glucosyltransferase activity | 2.10e-03 | 13 | 106 | 2 | GO:0035251 | |
| GeneOntologyMolecularFunction | retinoid binding | 2.11e-03 | 48 | 106 | 3 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.24e-03 | 49 | 106 | 3 | GO:0019840 | |
| GeneOntologyMolecularFunction | organic acid binding | 2.36e-03 | 254 | 106 | 6 | GO:0043177 | |
| GeneOntologyMolecularFunction | D-glucose binding | 2.44e-03 | 14 | 106 | 2 | GO:0005536 | |
| GeneOntologyMolecularFunction | glutamate binding | 2.44e-03 | 14 | 106 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.55e-03 | 107 | 106 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 3.19e-03 | 16 | 106 | 2 | GO:0004697 | |
| GeneOntologyBiologicalProcess | positive regulation of cell growth | 1.44e-05 | 213 | 106 | 8 | GO:0030307 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | EPHX1 EPHX2 GAD1 GAD2 ACACA UGT1A5 ANKRD26 DCAF5 UGT1A4 UGT1A3 ACSL4 MFSD2A MTOR ALOX15 | 2.26e-05 | 731 | 106 | 14 | GO:0032787 |
| GeneOntologyBiologicalProcess | gamma-aminobutyrate shunt | 2.62e-05 | 2 | 106 | 2 | GO:0006540 | |
| GeneOntologyBiologicalProcess | response to cocaine | 3.24e-05 | 71 | 106 | 5 | GO:0042220 | |
| GeneOntologyBiologicalProcess | TOR signaling | 4.19e-05 | 181 | 106 | 7 | GO:0031929 | |
| GeneOntologyBiologicalProcess | positive regulation of growth | 6.38e-05 | 339 | 106 | 9 | GO:0045927 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | RASSF2 PTPN22 MAP3K4 PTK2B TRAF4 EGFR MTOR PKN1 FGR PDGFC MAP2K5 NOTCH2 | 7.14e-05 | 611 | 106 | 12 | GO:0045859 |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | EPHX1 EPHX2 GAD1 GAD2 ACACA UGT1A5 AMDHD2 ANKRD26 DCAF5 UGT1A4 UGT1A3 ACSL4 MFSD2A MTOR AASS ALOX15 | 7.54e-05 | 1035 | 106 | 16 | GO:0019752 |
| GeneOntologyBiologicalProcess | regulation of engulfment of apoptotic cell | 7.82e-05 | 3 | 106 | 2 | GO:1901074 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 8.14e-05 | 350 | 106 | 9 | GO:0045860 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | PLA2G7 ROBO4 SEMA4D RPS6KB1 PTPN22 APOH PLXNB2 ACTR3 PTK2B EGFR MTOR PKN1 MST1L PLCG1 FGR PDGFC MAP2K5 WDR62 | 8.67e-05 | 1280 | 106 | 18 | GO:2000145 |
| GeneOntologyBiologicalProcess | tube development | ROBO4 SPINK2 APOH PLXNB2 PTK2B TRAF4 OR10J5 PBRM1 EGFR UBP1 SEC24B POFUT1 MST1L PLCG1 MAPK7 PDGFC MAP2K5 ENPEP NOTCH2 | 8.78e-05 | 1402 | 106 | 19 | GO:0035295 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | EPHX1 EPHX2 GAD1 GAD2 ACACA UGT1A5 AMDHD2 ANKRD26 DCAF5 UGT1A4 UGT1A3 ACSL4 MFSD2A MTOR AASS ALOX15 | 9.75e-05 | 1058 | 106 | 16 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | EPHX1 EPHX2 GAD1 GAD2 ACACA UGT1A5 AMDHD2 ANKRD26 DCAF5 UGT1A4 UGT1A3 ACSL4 MFSD2A MTOR AASS ALOX15 | 1.04e-04 | 1064 | 106 | 16 | GO:0006082 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | SEMA4D RASSF2 RPS6KB1 SRMS PTPN22 ABCA7 MAP3K4 PTK2B TRAF4 AGO3 EGFR MTOR USP32 FGR PDGFC MAP2K5 NOTCH2 ALOX15 | 1.05e-04 | 1299 | 106 | 18 | GO:1902533 |
| GeneOntologyBiologicalProcess | regulation of locomotion | PLA2G7 ROBO4 SEMA4D RPS6KB1 PTPN22 APOH PLXNB2 ACTR3 PTK2B EGFR MTOR PKN1 MST1L PLCG1 FGR PDGFC MAP2K5 WDR62 | 1.37e-04 | 1327 | 106 | 18 | GO:0040012 |
| GeneOntologyBiologicalProcess | regulation of cell migration | PLA2G7 ROBO4 SEMA4D RPS6KB1 PTPN22 APOH PLXNB2 ACTR3 PTK2B EGFR MTOR MST1L PLCG1 FGR PDGFC MAP2K5 WDR62 | 1.43e-04 | 1211 | 106 | 17 | GO:0030334 |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.64e-04 | 21 | 106 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | RASSF2 PTPN22 ABCA7 MAP3K4 PTK2B TRAF4 EGFR PDGFC MAP2K5 NOTCH2 ALOX15 | 1.72e-04 | 571 | 106 | 11 | GO:0043410 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 1.77e-04 | 228 | 106 | 7 | GO:0046777 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 1.88e-04 | 307 | 106 | 8 | GO:0018105 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine autophosphorylation | 1.89e-04 | 22 | 106 | 3 | GO:0038083 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | ROBO4 APOH PLXNB2 PTK2B OR10J5 PBRM1 EGFR UBP1 SEC24B POFUT1 MST1L PLCG1 MAPK7 MAP2K5 ENPEP NOTCH2 | 1.97e-04 | 1125 | 106 | 16 | GO:0035239 |
| GeneOntologyBiologicalProcess | regulation of kinase activity | RASSF2 PTPN22 MAP3K4 PTK2B TRAF4 EGFR MTOR PKN1 FGR PDGFC MAP2K5 NOTCH2 | 2.11e-04 | 686 | 106 | 12 | GO:0043549 |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle cell apoptotic process | 2.17e-04 | 23 | 106 | 3 | GO:0034392 | |
| GeneOntologyBiologicalProcess | cellular response to fluid shear stress | 2.17e-04 | 23 | 106 | 3 | GO:0071498 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | RASSF2 MAP3K4 PTK2B C1GALT1C1 TRAF4 EGFR MTOR PDGFC MAP2K5 NOTCH2 | 2.17e-04 | 490 | 106 | 10 | GO:0051347 |
| GeneOntologyBiologicalProcess | positive regulation of actin filament polymerization | 2.41e-04 | 59 | 106 | 4 | GO:0030838 | |
| GeneOntologyBiologicalProcess | positive regulation of ERK1 and ERK2 cascade | 2.43e-04 | 240 | 106 | 7 | GO:0070374 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 2.43e-04 | 319 | 106 | 8 | GO:0018209 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 2.43e-04 | 405 | 106 | 9 | GO:0033674 | |
| GeneOntologyBiologicalProcess | TORC1 signaling | 2.49e-04 | 109 | 106 | 5 | GO:0038202 | |
| GeneOntologyBiologicalProcess | epoxide metabolic process | 2.59e-04 | 5 | 106 | 2 | GO:0097176 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | RASSF2 PTPN22 MAP3K4 PTK2B C1GALT1C1 TRAF4 EGFR MTOR PKN1 FGR PDGFC MAP2K5 NOTCH2 | 2.63e-04 | 810 | 106 | 13 | GO:0051338 |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | ROBO4 APOH PTK2B OR10J5 PBRM1 UBP1 SEC24B POFUT1 PLCG1 MAPK7 MAP2K5 ENPEP NOTCH2 | 2.86e-04 | 817 | 106 | 13 | GO:0048514 |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 2.87e-04 | 327 | 106 | 8 | GO:0018108 | |
| GeneOntologyBiologicalProcess | regulation of lipid metabolic process | 2.91e-04 | 415 | 106 | 9 | GO:0019216 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 2.99e-04 | 329 | 106 | 8 | GO:0018212 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 3.15e-04 | 26 | 106 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 3.15e-04 | 26 | 106 | 3 | GO:0006063 | |
| GeneOntologyBiologicalProcess | regulation of heterotypic cell-cell adhesion | 3.53e-04 | 27 | 106 | 3 | GO:0034114 | |
| GeneOntologyBiologicalProcess | heterotypic cell-cell adhesion | 3.72e-04 | 66 | 106 | 4 | GO:0034113 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid biosynthetic process | 3.87e-04 | 6 | 106 | 2 | GO:0009449 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 4.37e-04 | 29 | 106 | 3 | GO:0045948 | |
| GeneOntologyBiologicalProcess | ether metabolic process | 4.37e-04 | 29 | 106 | 3 | GO:0018904 | |
| GeneOntologyBiologicalProcess | response to alkaloid | 4.69e-04 | 125 | 106 | 5 | GO:0043279 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | SEMA4D RASSF2 RPS6KA1 RPS6KB1 RPS6KB2 SRMS PTPN22 PTK2B EGFR MTOR PKN1 FGR MAPK7 PDGFC | 4.70e-04 | 976 | 106 | 14 | GO:0018193 |
| GeneOntologyBiologicalProcess | response to nutrient | 4.75e-04 | 192 | 106 | 6 | GO:0007584 | |
| GeneOntologyBiologicalProcess | cell activation | RPS6KA1 CD55 POU2AF1 PTPN22 DGKH PTK2B C1GALT1C1 PBRM1 SATB1 EGFR MTOR NECTIN2 PKN1 FGR HSPA4 VCAM1 NOTCH2 | 5.34e-04 | 1356 | 106 | 17 | GO:0001775 |
| GeneOntologyBiologicalProcess | ERK5 cascade | 5.40e-04 | 7 | 106 | 2 | GO:0070375 | |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | 6.23e-04 | 461 | 106 | 9 | GO:0006631 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 6.44e-04 | 134 | 106 | 5 | GO:0019217 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | SEMA4D RASSF2 PTPN22 PLXNB2 MAP3K4 PTK2B TRAF4 EGFR MTOR PKN1 FGR PDGFC MAP2K5 HSPA4 NOTCH2 | 6.73e-04 | 1133 | 106 | 15 | GO:0001932 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid metabolic process | 7.18e-04 | 8 | 106 | 2 | GO:0009448 | |
| GeneOntologyBiologicalProcess | glutamate catabolic process | 7.18e-04 | 8 | 106 | 2 | GO:0006538 | |
| GeneOntologyBiologicalProcess | response to fluid shear stress | 7.66e-04 | 35 | 106 | 3 | GO:0034405 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | 7.80e-04 | 577 | 106 | 10 | GO:0001667 | |
| GeneOntologyBiologicalProcess | lipid modification | 8.38e-04 | 214 | 106 | 6 | GO:0030258 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 8.42e-04 | 385 | 106 | 8 | GO:0070372 | |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | PLA2G7 SEMA4D RPS6KB1 ACTR3 PTK2B EGFR MTOR PLCG1 FGR PDGFC WDR62 | 8.55e-04 | 691 | 106 | 11 | GO:0030335 |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 9.01e-04 | 217 | 106 | 6 | GO:0051897 | |
| GeneOntologyBiologicalProcess | cellular response to laminar fluid shear stress | 9.20e-04 | 9 | 106 | 2 | GO:0071499 | |
| GeneOntologyBiologicalProcess | succinate metabolic process | 9.20e-04 | 9 | 106 | 2 | GO:0006105 | |
| GeneOntologyBiologicalProcess | vitamin D3 metabolic process | 9.20e-04 | 9 | 106 | 2 | GO:0070640 | |
| GeneOntologyBiologicalProcess | blood vessel development | ROBO4 APOH PTK2B OR10J5 PBRM1 UBP1 SEC24B POFUT1 PLCG1 MAPK7 MAP2K5 ENPEP NOTCH2 | 9.53e-04 | 929 | 106 | 13 | GO:0001568 |
| GeneOntologyBiologicalProcess | MAPK cascade | RASSF2 ANKRD26 PTPN22 ABCA7 MAP3K4 PTK2B TRAF4 EGFR MAPK7 PDGFC MAP2K5 NOTCH2 ALOX15 | 9.62e-04 | 930 | 106 | 13 | GO:0000165 |
| GeneOntologyBiologicalProcess | mature B cell differentiation involved in immune response | 9.76e-04 | 38 | 106 | 3 | GO:0002313 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | RASSF2 ANKRD26 PTPN22 ABCA7 MAP3K4 PTK2B TRAF4 EGFR PDGFC MAP2K5 NOTCH2 ALOX15 | 9.77e-04 | 815 | 106 | 12 | GO:0043408 |
| GeneOntologyBiologicalProcess | angiogenesis | ROBO4 APOH PTK2B OR10J5 UBP1 POFUT1 PLCG1 MAPK7 MAP2K5 ENPEP NOTCH2 | 1.04e-03 | 708 | 106 | 11 | GO:0001525 |
| GeneOntologyBiologicalProcess | negative regulation of muscle cell apoptotic process | 1.06e-03 | 87 | 106 | 4 | GO:0010656 | |
| GeneOntologyBiologicalProcess | circulatory system development | ROBO4 APOH PTK2B OR10J5 PBRM1 EGFR MTOR UBP1 GYS1 SEC24B POFUT1 PLCG1 MAPK7 MAP2K5 ENPEP VCAM1 NOTCH2 | 1.06e-03 | 1442 | 106 | 17 | GO:0072359 |
| GeneOntologyBiologicalProcess | non-canonical NF-kappaB signal transduction | 1.07e-03 | 150 | 106 | 5 | GO:0038061 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 1.10e-03 | 151 | 106 | 5 | GO:0045727 | |
| GeneOntologyBiologicalProcess | marginal zone B cell differentiation | 1.15e-03 | 10 | 106 | 2 | GO:0002315 | |
| GeneOntologyBiologicalProcess | cholangiocyte proliferation | 1.15e-03 | 10 | 106 | 2 | GO:1990705 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.17e-03 | 313 | 106 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | SEMA4D RASSF2 RPS6KB1 RPS6KB2 PTPN22 SEC22B PLXNB2 MAP3K4 PTK2B TRAF4 EGFR MTOR UBR3 MAPK7 PDGFC MAP2K5 NOTCH2 | 1.20e-03 | 1458 | 106 | 17 | GO:0051247 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ROBO4 SEMA4D CD55 PTPN22 PLXNB2 FAT2 PBRM1 EGFR MTOR NECTIN2 MAPK7 MAP2K5 VCAM1 ALOX15 | 1.23e-03 | 1077 | 106 | 14 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | PLA2G7 SEMA4D RPS6KB1 ACTR3 PTK2B EGFR MTOR PLCG1 FGR PDGFC WDR62 | 1.26e-03 | 725 | 106 | 11 | GO:2000147 |
| GeneOntologyBiologicalProcess | regulation of TOR signaling | 1.35e-03 | 158 | 106 | 5 | GO:0032006 | |
| GeneOntologyCellularComponent | Golgi membrane | GAD2 CHST10 COPA CD55 SEC22B ABCA7 ACTR3 C1GALT1C1 EGFR MTOR USP32 PDGFC NOTCH2 | 9.76e-05 | 721 | 109 | 13 | GO:0000139 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | EPHX1 COPA UGT1A5 SEC22B EMC8 UGT1A4 UGT1A3 ACSL4 MFSD2A OR10J5 EGFR MTOR NUP210 SEC24B KLHL14 OR7A2P NOTCH2 | 3.72e-04 | 1293 | 109 | 17 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | EPHX1 COPA UGT1A5 SEC22B EMC8 UGT1A4 UGT1A3 ACSL4 MFSD2A OR10J5 EGFR MTOR NUP210 SEC24B KLHL14 OR7A2P NOTCH2 | 3.92e-04 | 1299 | 109 | 17 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | EPHX1 COPA UGT1A5 SEC22B EMC8 UGT1A4 UGT1A3 ACSL4 MFSD2A OR10J5 EGFR MTOR NUP210 SEC24B KLHL14 OR7A2P NOTCH2 | 5.00e-04 | 1327 | 109 | 17 | GO:0042175 |
| GeneOntologyCellularComponent | coated vesicle | 6.01e-04 | 360 | 109 | 8 | GO:0030135 | |
| GeneOntologyCellularComponent | clathrin-sculpted gamma-aminobutyric acid transport vesicle | 7.39e-04 | 8 | 109 | 2 | GO:0061200 | |
| GeneOntologyCellularComponent | clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane | 7.39e-04 | 8 | 109 | 2 | GO:0061202 | |
| GeneOntologyCellularComponent | ruffle | 7.43e-04 | 206 | 109 | 6 | GO:0001726 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 9.27e-04 | 215 | 109 | 6 | GO:0030662 | |
| MousePheno | ventricular hypoplasia | 2.45e-06 | 99 | 86 | 7 | MP:0000279 | |
| MousePheno | heart hypoplasia | 3.20e-06 | 103 | 86 | 7 | MP:0002740 | |
| MousePheno | small heart | CASZ1 ACSL4 PBRM1 UBP1 GYS1 SEC24B POFUT1 MAPK7 VCAM1 NOTCH2 | 2.68e-05 | 321 | 86 | 10 | MP:0002188 |
| MousePheno | ventricle myocardium hypoplasia | 7.42e-05 | 71 | 86 | 5 | MP:0010502 | |
| MousePheno | abnormal embryonic growth/weight/body size | ACACA SZT2 RPS6KB1 EFTUD2 MFSD2A C1GALT1C1 TRAF4 EGFR MTOR UBP1 GYS1 SEC24B BICRAL POFUT1 PLCG1 MAPK7 MAP2K5 VCAM1 NOTCH2 DNMT3A | 8.88e-05 | 1295 | 86 | 20 | MP:0002088 |
| Domain | Protein_kinase_ATP_BS | RPS6KA1 RPS6KB1 RPS6KB2 SRMS MAP3K4 PRKD3 PTK2B EGFR PKN1 FGR MAPK7 MAP2K5 | 1.62e-06 | 379 | 106 | 12 | IPR017441 |
| Domain | PROTEIN_KINASE_ATP | RPS6KA1 RPS6KB1 RPS6KB2 SRMS MAP3K4 PRKD3 PTK2B EGFR PKN1 FGR MAPK7 MAP2K5 | 1.15e-05 | 459 | 106 | 12 | PS00107 |
| Domain | Kinase-like_dom | RPS6KA1 RPS6KB1 RPS6KB2 SRMS MAP3K4 PRKD3 PTK2B EGFR MTOR PKN1 FGR MAPK7 MAP2K5 | 1.21e-05 | 542 | 106 | 13 | IPR011009 |
| Domain | Prot_kinase_dom | RPS6KA1 RPS6KB1 RPS6KB2 SRMS MAP3K4 PRKD3 PTK2B EGFR PKN1 FGR MAPK7 MAP2K5 | 2.15e-05 | 489 | 106 | 12 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | RPS6KA1 RPS6KB1 RPS6KB2 SRMS MAP3K4 PRKD3 PTK2B EGFR PKN1 FGR MAPK7 MAP2K5 | 2.32e-05 | 493 | 106 | 12 | PS50011 |
| Domain | Glycogen_syn | 3.19e-05 | 2 | 106 | 2 | PF05693 | |
| Domain | Glycogen_synth | 3.19e-05 | 2 | 106 | 2 | IPR008631 | |
| Domain | Ribosomal_S6_kinase | 3.19e-05 | 2 | 106 | 2 | IPR016238 | |
| Domain | Pkinase_C | 5.60e-05 | 37 | 106 | 4 | IPR017892 | |
| Domain | Pkinase_C | 9.29e-05 | 42 | 106 | 4 | PF00433 | |
| Domain | Apc4_WD40_dom | 1.89e-04 | 20 | 106 | 3 | IPR024977 | |
| Domain | ANAPC4_WD40 | 1.89e-04 | 20 | 106 | 3 | PF12894 | |
| Domain | UDPGT | 2.19e-04 | 21 | 106 | 3 | PF00201 | |
| Domain | UDPGT | 2.19e-04 | 21 | 106 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 2.19e-04 | 21 | 106 | 3 | IPR002213 | |
| Domain | AGC-kinase_C | 2.87e-04 | 56 | 106 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 2.87e-04 | 56 | 106 | 4 | PS51285 | |
| Domain | S_TK_X | 2.87e-04 | 56 | 106 | 4 | SM00133 | |
| Domain | Pyridoxal-P_BS | 3.16e-04 | 5 | 106 | 2 | IPR021115 | |
| Domain | PyrdxlP-dep_de-COase | 8.74e-04 | 8 | 106 | 2 | IPR002129 | |
| Domain | Epox_hydrolase-like | 8.74e-04 | 8 | 106 | 2 | IPR000639 | |
| Domain | Pyridoxal_deC | 8.74e-04 | 8 | 106 | 2 | PF00282 | |
| Domain | DDC_GAD_HDC_YDC | 8.74e-04 | 8 | 106 | 2 | PS00392 | |
| Domain | Ser/Thr_kinase_AS | 9.77e-04 | 357 | 106 | 8 | IPR008271 | |
| Domain | S_TKc | 1.01e-03 | 359 | 106 | 8 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.07e-03 | 362 | 106 | 8 | PS00108 | |
| Domain | Pkinase | 1.48e-03 | 381 | 106 | 8 | PF00069 | |
| Domain | Tyr_kinase_cat_dom | 1.59e-03 | 88 | 106 | 4 | IPR020635 | |
| Domain | TyrKc | 1.59e-03 | 88 | 106 | 4 | SM00219 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 2.40e-07 | 10 | 84 | 4 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 3.75e-07 | 11 | 84 | 4 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 3.75e-07 | 11 | 84 | 4 | M47501 | |
| Pathway | WP_INSULIN_SIGNALING | 4.44e-07 | 160 | 84 | 9 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 4.44e-07 | 160 | 84 | 9 | M39482 | |
| Pathway | WP_EGFEGFR_SIGNALING | 4.93e-07 | 162 | 84 | 9 | M39334 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 5.60e-07 | 12 | 84 | 4 | M47393 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 1.15e-06 | 132 | 84 | 8 | M39338 | |
| Pathway | WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING | 2.79e-06 | 67 | 84 | 6 | M39630 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 5.85e-06 | 76 | 84 | 6 | MM1433 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 7.02e-06 | 7 | 84 | 3 | M47407 | |
| Pathway | WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS | 7.54e-06 | 46 | 84 | 5 | M39805 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 8.49e-06 | 81 | 84 | 6 | M13863 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 1.05e-05 | 84 | 84 | 6 | M39839 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.39e-05 | 52 | 84 | 5 | M14171 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | 2.36e-05 | 144 | 84 | 7 | M39691 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 3.25e-05 | 11 | 84 | 3 | M47403 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 3.25e-05 | 11 | 84 | 3 | M47484 | |
| Pathway | WP_BDNFTRKB_SIGNALING | 4.21e-05 | 33 | 84 | 4 | M39532 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 5.59e-05 | 13 | 84 | 3 | M47398 | |
| Pathway | BIOCARTA_ERK5_PATHWAY | 7.09e-05 | 14 | 84 | 3 | MM1481 | |
| Pathway | BIOCARTA_ERK5_PATHWAY | 7.09e-05 | 14 | 84 | 3 | M16811 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 8.82e-05 | 15 | 84 | 3 | M47663 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 8.82e-05 | 15 | 84 | 3 | MM15697 | |
| Pathway | WP_LEPTIN_SIGNALING | 8.83e-05 | 76 | 84 | 5 | M39491 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 1.08e-04 | 16 | 84 | 3 | MM15477 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.28e-04 | 188 | 84 | 7 | MM15828 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.33e-04 | 44 | 84 | 4 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.45e-04 | 45 | 84 | 4 | MM15694 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 1.56e-04 | 18 | 84 | 3 | M657 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 1.65e-04 | 137 | 84 | 6 | M18155 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 1.68e-04 | 87 | 84 | 5 | M12467 | |
| Pathway | REACTOME_HEME_DEGRADATION | 2.16e-04 | 20 | 84 | 3 | MM14721 | |
| Pathway | WP_ERBB_SIGNALING | 2.18e-04 | 92 | 84 | 5 | M39715 | |
| Pathway | WP_NETRINUNC5B_SIGNALING | 2.55e-04 | 52 | 84 | 4 | M39782 | |
| Pathway | KEGG_MTOR_SIGNALING_PATHWAY | 2.55e-04 | 52 | 84 | 4 | M7561 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | RASSF2 RPS6KA1 RPS6KB1 RPS6KB2 MAP3K4 EGFR MTOR MAPK7 PDGFC MAP2K5 | 2.72e-04 | 439 | 84 | 10 | M42563 |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 3.00e-04 | 153 | 84 | 6 | MM15844 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 3.22e-04 | 100 | 84 | 5 | MM15826 | |
| Pathway | REACTOME_PREDNISONE_ADME | 3.32e-04 | 23 | 84 | 3 | MM16639 | |
| Pathway | BIOCARTA_ION_PATHWAY | 3.47e-04 | 5 | 84 | 2 | MM1574 | |
| Pathway | BIOCARTA_ION_PATHWAY | 3.47e-04 | 5 | 84 | 2 | M22059 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.77e-04 | 24 | 84 | 3 | MM14599 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 4.03e-04 | 105 | 84 | 5 | M164 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.27e-04 | 25 | 84 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 4.27e-04 | 25 | 84 | 3 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 4.27e-04 | 25 | 84 | 3 | M605 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 4.30e-04 | 302 | 84 | 8 | M39719 | |
| Pathway | WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING | 4.59e-04 | 108 | 84 | 5 | M48078 | |
| Pathway | WP_THERMOGENESIS | 4.59e-04 | 108 | 84 | 5 | M39746 | |
| Pathway | WP_GLUCURONIDATION | 4.81e-04 | 26 | 84 | 3 | M39404 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_BIOSYNTHESIS | 5.18e-04 | 6 | 84 | 2 | M47620 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 5.18e-04 | 6 | 84 | 2 | M27068 | |
| Pathway | WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING | 5.38e-04 | 27 | 84 | 3 | M39609 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 6.00e-04 | 28 | 84 | 3 | M19580 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 7.11e-04 | 326 | 84 | 8 | MM15917 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 7.75e-04 | 183 | 84 | 6 | M39588 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 7.98e-04 | 70 | 84 | 4 | M16794 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 8.13e-04 | 31 | 84 | 3 | M47396 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 8.38e-04 | 418 | 84 | 9 | MM15587 | |
| Pathway | WP_FOCAL_ADHESION | 8.67e-04 | 187 | 84 | 6 | MM15913 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 8.67e-04 | 187 | 84 | 6 | M961 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 8.94e-04 | 32 | 84 | 3 | MM14719 | |
| Pathway | WP_PI3KAKT_SIGNALING | 9.17e-04 | 339 | 84 | 8 | M39736 | |
| Pathway | WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION | 9.60e-04 | 8 | 84 | 2 | M39537 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 9.60e-04 | 8 | 84 | 2 | M47394 | |
| Pathway | WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION | 9.60e-04 | 8 | 84 | 2 | M39447 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY | 9.60e-04 | 8 | 84 | 2 | M47479 | |
| Pathway | REACTOME_CARGO_CONCENTRATION_IN_THE_ER | 9.79e-04 | 33 | 84 | 3 | M27591 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 9.83e-04 | 74 | 84 | 4 | M39857 | |
| Pathway | PID_MAPK_TRK_PATHWAY | 1.07e-03 | 34 | 84 | 3 | M270 | |
| Pathway | REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA | 1.23e-03 | 9 | 84 | 2 | M27133 | |
| Pathway | REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA | 1.23e-03 | 9 | 84 | 2 | MM14853 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 1.23e-03 | 9 | 84 | 2 | M47481 | |
| Pathway | REACTOME_CARGO_CONCENTRATION_IN_THE_ER | 1.26e-03 | 36 | 84 | 3 | MM15300 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 1.29e-03 | 202 | 84 | 6 | MM15650 | |
| Pathway | WP_G13_SIGNALING | 1.48e-03 | 38 | 84 | 3 | M39606 | |
| Pathway | KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM | 1.53e-03 | 10 | 84 | 2 | M12882 | |
| Pathway | WP_G13_SIGNALING_PATHWAY | 1.60e-03 | 39 | 84 | 3 | MM15898 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 1.72e-03 | 86 | 84 | 4 | M39375 | |
| Pathway | WP_IL5_SIGNALING | 1.72e-03 | 40 | 84 | 3 | M39392 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 1.80e-03 | 293 | 84 | 7 | MM15120 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.85e-03 | 41 | 84 | 3 | M7399 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 1.86e-03 | 11 | 84 | 2 | M47812 | |
| Pathway | WP_GABA_METABOLISM_AKA_GHB | 1.86e-03 | 11 | 84 | 2 | M42550 | |
| Pathway | WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS | 1.87e-03 | 88 | 84 | 4 | M39495 | |
| Pathway | WP_PANCREATIC_ADENOCARCINOMA_PATHWAY | 1.95e-03 | 89 | 84 | 4 | M39732 | |
| Pathway | WP_IL2_SIGNALING | 1.98e-03 | 42 | 84 | 3 | M39536 | |
| Pathway | KEGG_GAP_JUNCTION | 2.03e-03 | 90 | 84 | 4 | M4013 | |
| Pathway | WP_ALANINE_AND_ASPARTATE_METABOLISM | 2.23e-03 | 12 | 84 | 2 | M39331 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 2.25e-03 | 154 | 84 | 5 | M39739 | |
| Pathway | WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS | 2.27e-03 | 44 | 84 | 3 | M46452 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 2.35e-03 | 307 | 84 | 7 | M894 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 2.38e-03 | 156 | 84 | 5 | M27097 | |
| Pathway | WP_ERBB_SIGNALING_PATHWAY | 2.58e-03 | 46 | 84 | 3 | MM15950 | |
| Pathway | WP_DISORDERS_OF_GALACTOSE_METABOLISM | 2.62e-03 | 13 | 84 | 2 | M45545 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 3.05e-03 | 14 | 84 | 2 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY | 3.05e-03 | 14 | 84 | 2 | M47383 | |
| Pathway | REACTOME_GLYCOGEN_SYNTHESIS | 3.05e-03 | 14 | 84 | 2 | M27247 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 3.09e-03 | 101 | 84 | 4 | M1979 | |
| Pubmed | 1.14e-08 | 9 | 109 | 4 | 21035469 | ||
| Pubmed | mTOR/S6 kinase pathway contributes to astrocyte survival during ischemia. | 2.99e-08 | 3 | 109 | 3 | 19535330 | |
| Pubmed | Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer. | 2.99e-08 | 3 | 109 | 3 | 32054043 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 19881535 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 15905173 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 11914378 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 15895362 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 21444676 | ||
| Pubmed | Cytoplasmic TRAF4 contributes to the activation of p70s6k signaling pathway in breast cancer. | 1.20e-07 | 4 | 109 | 3 | 25738361 | |
| Pubmed | 1.76e-07 | 192 | 109 | 8 | 20602615 | ||
| Pubmed | 2.83e-07 | 371 | 109 | 10 | 25241761 | ||
| Pubmed | S6K1 Is Required for Increasing Skeletal Muscle Force during Hypertrophy. | 2.98e-07 | 5 | 109 | 3 | 27705797 | |
| Pubmed | 2.98e-07 | 5 | 109 | 3 | 24967341 | ||
| Pubmed | 2.98e-07 | 5 | 109 | 3 | 21501832 | ||
| Pubmed | The mTOR pathway negatively controls ATM by up-regulating miRNAs. | 2.98e-07 | 5 | 109 | 3 | 23818585 | |
| Pubmed | Mammalian EAK-7 activates alternative mTOR signaling to regulate cell proliferation and migration. | 2.98e-07 | 5 | 109 | 3 | 29750193 | |
| Pubmed | mTOR and S6K1 drive polycystic kidney by the control of Afadin-dependent oriented cell division. | 2.98e-07 | 5 | 109 | 3 | 32581239 | |
| Pubmed | Epiregulin and EGFR interactions are involved in pain processing. | 5.95e-07 | 6 | 109 | 3 | 28783046 | |
| Pubmed | Distinct regulatory mechanism for p70 S6 kinase beta from that for p70 S6 kinase alpha. | 5.95e-07 | 6 | 109 | 3 | 11733037 | |
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 22711699 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | RASSF2 RPS6KA1 RPS6KB1 RPS6KB2 MAP3K4 PRKD3 PTK2B AGO3 EGFR PKN1 PLCG1 MAPK7 MAP2K5 HSPA4 | 1.02e-06 | 910 | 109 | 14 | 36736316 |
| Pubmed | 1.04e-06 | 7 | 109 | 3 | 18474609 | ||
| Pubmed | 1.66e-06 | 8 | 109 | 3 | 17043309 | ||
| Pubmed | 2.48e-06 | 9 | 109 | 3 | 22511988 | ||
| Pubmed | Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination. | 2.48e-06 | 9 | 109 | 3 | 24948799 | |
| Pubmed | 2.48e-06 | 9 | 109 | 3 | 22586265 | ||
| Pubmed | Phosphorylation of human microtubule-associated protein tau by protein kinases of the AGC subfamily. | 2.48e-06 | 9 | 109 | 3 | 17512525 | |
| Pubmed | 2.48e-06 | 9 | 109 | 3 | 22017876 | ||
| Pubmed | 2.48e-06 | 9 | 109 | 3 | 1339448 | ||
| Pubmed | 2.48e-06 | 9 | 109 | 3 | 28798047 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | EPHX1 GATD3 ACACA COPA SEC22B EMC8 PLXNB2 DCAF5 EFTUD2 ACSL4 C1GALT1C1 EGFR TAX1BP1 SEC24B POFUT1 NOTCH2 ALOX15 | 2.76e-06 | 1451 | 109 | 17 | 30550785 |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 2.77e-06 | 372 | 109 | 9 | 22939624 | |
| Pubmed | SEMA4D RPS6KA1 RPS6KB1 RPS6KB2 SRMS DGKH PLXNB2 ACSL4 PTK2B EGFR FGR MAP2K5 | 3.27e-06 | 730 | 109 | 12 | 34857952 | |
| Pubmed | A Role for Dystonia-Associated Genes in Spinal GABAergic Interneuron Circuitry. | 3.54e-06 | 10 | 109 | 3 | 29045835 | |
| Pubmed | Hsp70 associates with Rictor and is required for mTORC2 formation and activity. | 3.54e-06 | 10 | 109 | 3 | 18505677 | |
| Pubmed | 3.54e-06 | 10 | 109 | 3 | 23642732 | ||
| Pubmed | 3.54e-06 | 10 | 109 | 3 | 11465080 | ||
| Pubmed | 3.54e-06 | 10 | 109 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 3.54e-06 | 10 | 109 | 3 | 22558097 | |
| Pubmed | Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. | 4.85e-06 | 11 | 109 | 3 | 11500364 | |
| Pubmed | 4.85e-06 | 11 | 109 | 3 | 22717580 | ||
| Pubmed | 6.45e-06 | 12 | 109 | 3 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 6.45e-06 | 12 | 109 | 3 | 11434514 | |
| Pubmed | Distinct hyperactive RAS/MAPK alleles converge on common GABAergic interneuron core programs. | 8.37e-06 | 13 | 109 | 3 | 37254876 | |
| Pubmed | 8.37e-06 | 13 | 109 | 3 | 19805522 | ||
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 8.37e-06 | 13 | 109 | 3 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 8.37e-06 | 13 | 109 | 3 | 25246029 | |
| Pubmed | Late development of the GABAergic system in the human cerebral cortex and white matter. | 9.73e-06 | 2 | 109 | 2 | 21937910 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 36470481 | ||
| Pubmed | Subthalamic GAD gene therapy in a Parkinson's disease rat model. | 9.73e-06 | 2 | 109 | 2 | 12376704 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15659381 | ||
| Pubmed | Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin. | 9.73e-06 | 2 | 109 | 2 | 12087098 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 8068691 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 33003310 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 25600244 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 28927892 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 22219294 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16407298 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15760907 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16718280 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 2039509 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24641623 | ||
| Pubmed | Skeletal myocyte hypertrophy requires mTOR kinase activity and S6K1. | 9.73e-06 | 2 | 109 | 2 | 15963500 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 23220582 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 22332935 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 18513744 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21250934 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 34245854 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12628002 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 26347473 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24675012 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 17550782 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 19111404 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11692079 | ||
| Pubmed | Medullary Reticular Neurons Mediate Neuropeptide Y-Induced Metabolic Inhibition and Mastication. | 9.73e-06 | 2 | 109 | 2 | 28065829 | |
| Pubmed | Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells. | 9.73e-06 | 2 | 109 | 2 | 25061101 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 8524831 | ||
| Pubmed | An analysis of the cross-reactivity of autoantibodies to GAD65 and GAD67 in diabetes. | 9.73e-06 | 2 | 109 | 2 | 21494613 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 10631549 | ||
| Pubmed | PLCγ1‑dependent invasion and migration of cells expressing NSCLC‑associated EGFR mutants. | 9.73e-06 | 2 | 109 | 2 | 32945365 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 20215112 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 22986331 | ||
| Pubmed | Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. | 9.73e-06 | 2 | 109 | 2 | 15899889 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15657358 | ||
| Pubmed | The mTOR pathway is necessary for survival of mice with short telomeres. | 9.73e-06 | 2 | 109 | 2 | 32127537 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 18047830 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 29305864 | ||
| Pubmed | The FRB domain of mTOR: NMR solution structure and inhibitor design. | 9.73e-06 | 2 | 109 | 2 | 16922504 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 18767117 | ||
| Pubmed | Opioid-Induced Reductions in Amygdala Lateral Paracapsular GABA Neuron Circuit Activity. | 9.73e-06 | 2 | 109 | 2 | 36768252 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 19936974 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 23350658 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16452250 | ||
| Pubmed | mTOR and P70 S6 kinase expression in primary liver neoplasms. | 9.73e-06 | 2 | 109 | 2 | 15623621 | |
| Pubmed | Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells. | 9.73e-06 | 2 | 109 | 2 | 32286420 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24337579 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16478989 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 32020217 | ||
| Pubmed | The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer. | 9.73e-06 | 2 | 109 | 2 | 31969375 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 9326630 | ||
| Interaction | SYK interactions | RPS6KA1 RPS6KB1 RPS6KB2 POU2AF1 PTK2B PBRM1 EGFR PLCG1 FGR VCAM1 | 7.68e-07 | 251 | 105 | 10 | int:SYK |
| Interaction | PDPK1 interactions | 1.12e-05 | 203 | 105 | 8 | int:PDPK1 | |
| Interaction | DDA1 interactions | 2.26e-05 | 368 | 105 | 10 | int:DDA1 | |
| Interaction | DERL1 interactions | EPHX1 GAD2 COPA SMCHD1 SEC22B EMC8 PLXNB2 EGFR NUP210 SEC24B NOTCH2 | 2.45e-05 | 453 | 105 | 11 | int:DERL1 |
| Interaction | HSP90AB1 interactions | RPS6KA1 SPEF2 RPS6KB2 SRMS EFTUD2 AGO3 EGFR MTOR AASS TUBGCP3 PLCG1 FGR MAPK7 MAP2K5 HSPA4 VCAM1 | 3.61e-05 | 960 | 105 | 16 | int:HSP90AB1 |
| Interaction | PFDN2 interactions | 4.56e-05 | 247 | 105 | 8 | int:PFDN2 | |
| Interaction | CDC42 interactions | ACACA COPA RPS6KB1 ANKRD26 SRMS SEC22B EMC8 FNBP1L APOH PLXNB2 ACTR3 MAP3K4 ACSL4 AGO3 EGFR AASS NUP210 NECTIN2 NOTCH2 | 4.82e-05 | 1323 | 105 | 19 | int:CDC42 |
| Cytoband | 2q37 | 5.58e-05 | 31 | 109 | 3 | 2q37 | |
| GeneFamily | UDP glucuronosyltransferases | 2.88e-04 | 32 | 73 | 3 | 363 | |
| GeneFamily | Glycosyl transferases group 1 domain containing | 7.09e-04 | 10 | 73 | 2 | 427 | |
| GeneFamily | SH2 domain containing | 7.43e-04 | 101 | 73 | 4 | 741 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | EPHX1 PLA2G7 RPS6KB2 CD55 POU2AF1 TRAF4 SATB1 ENPEP HSPA4 VCAM1 ALOX15 | 1.01e-06 | 408 | 108 | 11 | M3284 |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | EPHX1 PLA2G7 RPS6KB2 CD55 POU2AF1 TRAF4 SATB1 ENPEP HSPA4 VCAM1 ALOX15 | 3.44e-06 | 463 | 108 | 11 | MM1011 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP | 4.61e-06 | 160 | 108 | 7 | M1346 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP | 5.87e-06 | 166 | 108 | 7 | MM563 | |
| Coexpression | FIRESTEIN_CTNNB1_PATHWAY | 8.97e-06 | 32 | 108 | 4 | M1489 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_UP | 1.97e-05 | 200 | 108 | 7 | M4948 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 3.23e-05 | 88 | 108 | 5 | MM1087 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.09e-07 | 170 | 109 | 7 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 2.18e-07 | 171 | 109 | 7 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | Mild-Treg|Mild / Disease group and Cell class | 2.86e-07 | 178 | 109 | 7 | e669fd95278e145f55126d0e6be8fb2d6184dbbd | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 3.99e-07 | 187 | 109 | 7 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.27e-07 | 200 | 109 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.27e-07 | 200 | 109 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-06 | 151 | 109 | 6 | 090b067873740c282865e2d02cf47d5cb3dd7607 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.29e-06 | 155 | 109 | 6 | 79264ff283e36a059040a5aa9fe7337be694cb52 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 158 | 109 | 6 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 158 | 109 | 6 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.56e-06 | 158 | 109 | 6 | 121d63b8e2e37107467b170e5b2c798a7dbf6325 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.76e-06 | 160 | 109 | 6 | bc4a93dc5f37829799c37877e751ff3bc122e4ab | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 161 | 109 | 6 | e227f7b711475624cf80e77f235b1783d88d57b4 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 161 | 109 | 6 | 8280a029026c272cae9649b27575831b0dd4e242 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.86e-06 | 161 | 109 | 6 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.29e-06 | 165 | 109 | 6 | dbe231d00843cae917efd1abea6079ace3b45cdf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.29e-06 | 165 | 109 | 6 | 9ccce713d4122054bf4bef4a7126d90cf9141b84 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.41e-06 | 166 | 109 | 6 | 59d47c1fca7a8c70f6998f3367a9dbcb9b67966f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-06 | 168 | 109 | 6 | 00cff4698db14e03ca1d1b409e5ed1ad23b12615 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-06 | 168 | 109 | 6 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-06 | 168 | 109 | 6 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.78e-06 | 169 | 109 | 6 | 90c00ab30e582b0e2a2be751e1fae9024cfb9ea6 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-06 | 171 | 109 | 6 | a31c23406cf6d6a17358a8fb41d392a7fb0306e0 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-06 | 171 | 109 | 6 | 43d8fd9b9546e84a652564fe96b514b34b06262b | |
| ToppCell | droplet-Fat-Mat-18m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-06 | 172 | 109 | 6 | 226de1a5d4a360d3ae01b0235fea19521ec623a0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.93e-06 | 177 | 109 | 6 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.93e-06 | 177 | 109 | 6 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-B_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-06 | 178 | 109 | 6 | 5b6f7e8a930c239db1f31edfb61b2b9228d28663 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.16e-06 | 184 | 109 | 6 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-06 | 186 | 109 | 6 | a8fcb440d88770f95678c5d28413fc4d847f42a8 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-06 | 186 | 109 | 6 | 6b2d15e2756d4d4d68ad600e4a6c074edc3488f2 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-06 | 186 | 109 | 6 | 683f59985fbc5d3ba2412c788b4647dbbf42699a | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 7.40e-06 | 190 | 109 | 6 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 190 | 109 | 6 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 7.40e-06 | 190 | 109 | 6 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 7.62e-06 | 191 | 109 | 6 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 7.62e-06 | 191 | 109 | 6 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.85e-06 | 192 | 109 | 6 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 8.09e-06 | 193 | 109 | 6 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | CV-Mild-5|Mild / Virus stimulation, Condition and Cluster | 8.09e-06 | 193 | 109 | 6 | 2053f0f8083b3174e1b6f76d2d7089f59982565d | |
| ToppCell | CV-Severe-5|CV / Virus stimulation, Condition and Cluster | 8.09e-06 | 193 | 109 | 6 | d87fcd4553b6198c3128685b73ffd1b1ae88fbb5 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 8.58e-06 | 195 | 109 | 6 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | CV-Healthy-5|Healthy / Virus stimulation, Condition and Cluster | 8.83e-06 | 196 | 109 | 6 | f121b009d64704177f73f2da3848f0ad6ed6bf1f | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-06 | 196 | 109 | 6 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | 3'-Broncho-tracheal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.09e-06 | 197 | 109 | 6 | 5d33f8a6940431093e927b186fb9b630a89d8ec1 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.09e-06 | 197 | 109 | 6 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-06 | 198 | 109 | 6 | 9718f4c013c347f1b3c785ae232dd2fb6c1fe298 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-06 | 198 | 109 | 6 | 89ec1e760a193441092571475cc66a3b425f232e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-06 | 198 | 109 | 6 | aa6e7218ee6230902854e66c444b544218b30c0e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-06 | 198 | 109 | 6 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.63e-06 | 199 | 109 | 6 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | distal-Hematologic-Classical_Monocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.63e-06 | 199 | 109 | 6 | bd8519da7a90f0b90626b86c6be0d62248a0a24a | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease, condition lineage and cell class | 9.91e-06 | 200 | 109 | 6 | 65ae349fac4084faacbc6a645a92398f6324770e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.98e-05 | 134 | 109 | 5 | 657ad905b40ec3f82acdef824431b8276d291ef7 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 140 | 109 | 5 | e442c46979d725ec82f525a001c46d971fcade4d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.71e-05 | 143 | 109 | 5 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.89e-05 | 145 | 109 | 5 | 8b13b576fd2e6e33ccb146860a91a53cee0cdd4d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.09e-05 | 147 | 109 | 5 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.19e-05 | 148 | 109 | 5 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | P03-Hematopoietic-Immune-immune_cell_unspecified|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.30e-05 | 149 | 109 | 5 | 43d756f81d532b5c7f2306e6af9d072d496cbc8e | |
| ToppCell | P03-Hematopoietic-Immune|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.30e-05 | 149 | 109 | 5 | 1c5a2572741c47246d455c865e8e1677c9f49598 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.63e-05 | 152 | 109 | 5 | eb7ff36792c3c54ac88cfe976f84016b70b1a1d7 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-05 | 154 | 109 | 5 | 27f76e4b3c055aa382708f1610c685f02d6d6114 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-05 | 154 | 109 | 5 | 8746663a822d93a8510081c81a8c971b51653067 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.98e-05 | 155 | 109 | 5 | d10cf5e922dbd3ca46660404da5aca43f181fc19 | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.11e-05 | 156 | 109 | 5 | 166f7b1220eaf8e1149dde260dd85a094855c54f | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.11e-05 | 156 | 109 | 5 | 5e1c5a7c9293b886920739cf766521df7f69726c | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 157 | 109 | 5 | 2b60de520edf167f5ca790b478557a778435b3d9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.63e-05 | 160 | 109 | 5 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 160 | 109 | 5 | 2020b6defbaf5b5db12af37f0103ac028a8ca76e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 160 | 109 | 5 | af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.91e-05 | 162 | 109 | 5 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-05 | 162 | 109 | 5 | 3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-05 | 162 | 109 | 5 | 8134f73eb76693f4f1845f643042fdc1e81c274c | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.91e-05 | 162 | 109 | 5 | 16d625ac6702f79a83af444d2b3bf6759fd17cf6 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-05 | 163 | 109 | 5 | bbbc3f0ce2616d07136f69ce682ba1d3790711d9 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 164 | 109 | 5 | 15d52666e5150e7c34b1f641a937fb2d5e8aaf8a | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 164 | 109 | 5 | d622f0d8d8bad48dfdf160ec63c545df192637a9 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.21e-05 | 164 | 109 | 5 | cd0794f84dfd346807e2d803723718b7f22e9232 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.21e-05 | 164 | 109 | 5 | 12251a49fd4af32d4edb58046245548c260cf04b | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.21e-05 | 164 | 109 | 5 | 11dfd84f5fb90de330858e1e852848832734e004 | |
| ToppCell | facs-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 165 | 109 | 5 | 720649f330382ea2a68c64a5344160a048afb8f1 | |
| ToppCell | facs-Heart-RA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 166 | 109 | 5 | fc2cf67311c86fda75b35fcd4768b6f6f14c59d0 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 166 | 109 | 5 | dd5944101ef58a9a29aa3eb5c17690119572b8f1 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 166 | 109 | 5 | 8e5e8de51b4dacdadaa5a08279df30b5c7ed3628 | |
| ToppCell | facs-Heart-RA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 166 | 109 | 5 | 33a6876d06e26176135a73a77c19e634ec53f7ce | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.52e-05 | 166 | 109 | 5 | b4241f8d2a0aa910dbb0d0d5d3631a9b73453fe9 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 168 | 109 | 5 | 68ef5d1043fca804032669bf990edf110d65cf63 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.84e-05 | 168 | 109 | 5 | c0aef5947b1d7e2c81a7481c509feda1687fcd7f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.84e-05 | 168 | 109 | 5 | 2572a3dd4f3f619bd26a3cd6e60de43821d8bb64 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.84e-05 | 168 | 109 | 5 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.84e-05 | 168 | 109 | 5 | c861f80aa12caf54a94d93e38539ff41dc5227a6 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-05 | 169 | 109 | 5 | 411556e93adcbb7e4d79b02f3dc72963ec8a0759 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-05 | 169 | 109 | 5 | 39b1acfd099abb9de18c29c05c7a67709ea76775 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.18e-05 | 170 | 109 | 5 | 7534ac69ca3a378df78d61c284e89bc96a71a4a8 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-05 | 170 | 109 | 5 | 7a4ed69c807c3761210776e8fe6680d1bd892e82 | |
| ToppCell | Mild-Treg|World / Disease group and Cell class | 6.18e-05 | 170 | 109 | 5 | f3f177534badca34e1ae8671b7f583ee6688e14b | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.71e-05 | 173 | 109 | 5 | e05cddf5bf63cf419343ff229453327519765be8 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 173 | 109 | 5 | 886ac1b98f709ad7131df778b83712bf8ed313de | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 173 | 109 | 5 | 807183fc23478da9451906dacd88de4e73112e0d | |
| Drug | estragole | 1.76e-10 | 34 | 105 | 7 | CID000008815 | |
| Drug | Pkcs | RPS6KB1 RPS6KB2 PRKD3 PTK2B EGFR MTOR GYS1 GYS2 PKN1 PLCG1 MAPK7 MAP2K5 | 2.69e-10 | 211 | 105 | 12 | CID000164073 |
| Drug | bisindolylmaleimide V | 2.89e-09 | 28 | 105 | 6 | CID000002400 | |
| Drug | NSC618487 | RPS6KB1 RPS6KB2 SRMS DGKH MAP3K4 PRKD3 PTK2B EGFR GYS1 GYS2 HRH1 PKN1 TNS4 PLCG1 FGR MAPK7 MAP2K5 ENPEP HSPA4 ALOX15 | 8.48e-09 | 933 | 105 | 20 | CID000005279 |
| Drug | cis isomer | 8.98e-09 | 58 | 105 | 7 | CID006474725 | |
| Drug | cholesterol alpha-oxide | 2.95e-08 | 8 | 105 | 4 | ctd:C002415 | |
| Drug | aspirin | GATD3 ACACA UGT1A5 F5 ACTR3 UGT1A4 UGT1A3 PTK2B GYS1 GYS2 PLCG1 MAPK7 HSPA4 VCAM1 ALOX15 | 4.71e-08 | 563 | 105 | 15 | CID000002244 |
| Drug | AC1L1G9T | RPS6KB1 RPS6KB2 SRMS PRKD3 PTK2B EGFR MTOR PLCG1 FGR MAPK7 MAP2K5 HSPA4 VCAM1 | 1.02e-07 | 433 | 105 | 13 | CID000003591 |
| Drug | DEPC | 1.60e-07 | 53 | 105 | 6 | CID000015357 | |
| Drug | vanadyl | RPS6KB1 RPS6KB2 PRKD3 PTK2B EGFR PKN1 PLCG1 MAPK7 MAP2K5 VCAM1 RPL10 | 1.81e-07 | 307 | 105 | 11 | CID000061671 |
| Drug | 4'-HPPH | 2.93e-07 | 31 | 105 | 5 | CID000017732 | |
| Drug | LY294002 | RPS6KA1 RPS6KB1 RPS6KB2 SRMS PRKD3 PTK2B EGFR MTOR GYS1 GYS2 PKN1 PLCG1 MAPK7 MAP2K5 HSPA4 VCAM1 | 3.23e-07 | 748 | 105 | 16 | CID000003973 |
| Drug | 2-butyl-6-methoxyphenol | 3.32e-07 | 197 | 105 | 9 | CID011954184 | |
| Drug | GF109203X | RPS6KB1 RPS6KB2 PRKD3 PTK2B EGFR MTOR HRH1 PKN1 PLCG1 MAPK7 MAP2K5 | 5.15e-07 | 341 | 105 | 11 | CID000002396 |
| Drug | AC1L9DGV | 6.38e-07 | 36 | 105 | 5 | CID000417381 | |
| Drug | BiM4 | RPS6KA1 RPS6KB1 RPS6KB2 PRKD3 PTK2B EGFR MTOR PKN1 MAPK7 MAP2K5 | 7.67e-07 | 283 | 105 | 10 | CID000002399 |
| Drug | AC1L1JYL | RPS6KB1 RPS6KB2 SRMS ABCA7 PRKD3 PTK2B EGFR MTOR PLCG1 MAPK7 MAP2K5 VCAM1 | 7.80e-07 | 434 | 105 | 12 | CID000005262 |
| Drug | 4-methylumbelliferyl glucuronide | 8.43e-07 | 38 | 105 | 5 | CID000091553 | |
| Drug | 1-Butanol | 8.60e-07 | 70 | 105 | 6 | ctd:D020001 | |
| Drug | SP600125 | RPS6KB1 RPS6KB2 MAP3K4 PRKD3 PTK2B EGFR MTOR MAPK7 MAP2K5 HSPA4 VCAM1 | 9.26e-07 | 362 | 105 | 11 | CID000008515 |
| Drug | wartmannin | RPS6KA1 RPS6KB1 RPS6KB2 SRMS PRKD3 PTK2B EGFR MTOR GYS1 GYS2 PKN1 PLCG1 MAPK7 MAP2K5 HSPA4 VCAM1 | 9.40e-07 | 811 | 105 | 16 | CID000005691 |
| Drug | geldanamicin | GAD1 GAD2 ACACA RPS6KB1 SRMS MLLT10 PTK2B EGFR MTOR HSPA4 VCAM1 | 1.24e-06 | 373 | 105 | 11 | CID000003460 |
| Drug | ApApG | 1.24e-06 | 18 | 105 | 4 | CID003081975 | |
| Drug | metformin | 1.45e-06 | 235 | 105 | 9 | CID000004091 | |
| Drug | AC1L1JM9 | RPS6KB1 PRKD3 PTK2B EGFR MTOR PKN1 MAPK7 MAP2K5 VCAM1 DNMT3A | 1.46e-06 | 304 | 105 | 10 | CID000005103 |
| Drug | 3-MA | 1.57e-06 | 19 | 105 | 4 | CID000447782 | |
| Drug | almokalant | 1.57e-06 | 19 | 105 | 4 | CID003033962 | |
| Drug | Kemptide | 1.75e-06 | 124 | 105 | 7 | CID000100074 | |
| Drug | (2S,3R)-Sphingosine | PLA2G7 DGKH ABCA7 EFTUD2 PRKD3 PTK2B PBRM1 EGFR PLCG1 MAPK7 VCAM1 | 1.86e-06 | 389 | 105 | 11 | CID000001104 |
| Drug | Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys | 1.89e-06 | 6 | 105 | 3 | CID003277749 | |
| Drug | AC1L1OBF | 1.95e-06 | 20 | 105 | 4 | CID000032736 | |
| Drug | trifluoperazine | ACACA UGT1A5 UGT1A4 PRKD3 UGT1A3 PTK2B GYS1 GYS2 HRH1 ALOX15 | 2.59e-06 | 324 | 105 | 10 | CID000005566 |
| Drug | amidoxime | 3.53e-06 | 23 | 105 | 4 | CID000465967 | |
| Drug | phenanthridine | 3.53e-06 | 23 | 105 | 4 | CID000009189 | |
| Drug | AG213 | 3.55e-06 | 89 | 105 | 6 | CID005328803 | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; PC3; HT_HG-U133A | 3.57e-06 | 196 | 105 | 8 | 4538_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.71e-06 | 197 | 105 | 8 | 3404_DN | |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.71e-06 | 197 | 105 | 8 | 2763_DN | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; MCF7; HT_HG-U133A | 3.71e-06 | 197 | 105 | 8 | 3265_DN | |
| Drug | Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A | 3.85e-06 | 198 | 105 | 8 | 5445_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 4.00e-06 | 199 | 105 | 8 | 1502_DN | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 4.00e-06 | 199 | 105 | 8 | 7494_DN | |
| Drug | Ornidazole [16773-42-5]; Down 200; 18.2uM; PC3; HT_HG-U133A | 4.00e-06 | 199 | 105 | 8 | 2109_DN | |
| Drug | AC1L1D59 | RPS6KA1 RPS6KB1 RPS6KB2 MAP3K4 PRKD3 PTK2B MTOR MAPK7 MAP2K5 | 4.01e-06 | 266 | 105 | 9 | CID000002199 |
| Drug | Ro 31 | 4.13e-06 | 141 | 105 | 7 | CID000214797 | |
| Drug | Stilbenes | 4.23e-06 | 24 | 105 | 4 | ctd:D013267 | |
| Drug | Akt inhibitor IV | 4.23e-06 | 24 | 105 | 4 | CID002326992 | |
| Drug | butylated hydroxytoluene | 4.53e-06 | 143 | 105 | 7 | CID000031404 | |
| Drug | enzastaurin | 4.56e-06 | 53 | 105 | 5 | CID000176166 | |
| Drug | P-38 | RPS6KB1 RPS6KB2 SRMS MAP3K4 PRKD3 PTK2B TRAF4 EGFR MTOR PKN1 MAP2K5 HSPA4 VCAM1 | 4.97e-06 | 613 | 105 | 13 | CID000200878 |
| Drug | 5,6-benzoquinoline | 5.01e-06 | 25 | 105 | 4 | CID000006796 | |
| Drug | N-phenylmaleimide | 5.01e-06 | 25 | 105 | 4 | CID000013662 | |
| Drug | phosphatidate | ACACA RPS6KB1 RPS6KB2 DGKH APOH PRKD3 PTK2B MTOR PLCG1 MAPK7 ALOX15 | 5.08e-06 | 432 | 105 | 11 | CID005460104 |
| Drug | saracatinib | 6.91e-06 | 27 | 105 | 4 | CID010302451 | |
| Drug | AC1MRQNQ | 7.85e-06 | 9 | 105 | 3 | CID003522271 | |
| Drug | DHPASiU | 7.85e-06 | 9 | 105 | 3 | CID000197602 | |
| Drug | 3-iodophenol | 7.85e-06 | 9 | 105 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 7.85e-06 | 9 | 105 | 3 | CID000186631 | |
| Drug | Chebi:32663 | 7.85e-06 | 9 | 105 | 3 | CID005460873 | |
| Drug | H-Ni | 8.03e-06 | 28 | 105 | 4 | CID000445665 | |
| Drug | 15-hydroxy-5,8,11,13-eicosatetraenoic acid | 8.03e-06 | 28 | 105 | 4 | ctd:C025984 | |
| Drug | eye gene | 8.15e-06 | 369 | 105 | 10 | CID000004782 | |
| Drug | K00077 | 8.35e-06 | 220 | 105 | 8 | CID006419759 | |
| Drug | 3-OH | 9.18e-06 | 61 | 105 | 5 | CID000068152 | |
| Drug | Phosphatidic Acids | 9.28e-06 | 29 | 105 | 4 | ctd:D010712 | |
| Drug | AICAR monophosphate | 1.07e-05 | 163 | 105 | 7 | CID000000200 | |
| Drug | LY303511 | 1.12e-05 | 10 | 105 | 3 | CID000003971 | |
| Drug | ketoprofen | 1.16e-05 | 64 | 105 | 5 | CID000003825 | |
| Drug | x MC | 1.22e-05 | 31 | 105 | 4 | CID000017563 | |
| Drug | PCB 156 | 1.22e-05 | 31 | 105 | 4 | CID000038019 | |
| Drug | PD98059 | 1.27e-05 | 233 | 105 | 8 | CID000004713 | |
| Drug | IN1076 | 1.34e-05 | 112 | 105 | 6 | CID000005309 | |
| Drug | Muracein C | 1.39e-05 | 32 | 105 | 4 | CID003086323 | |
| Drug | In-G | 1.41e-05 | 170 | 105 | 7 | CID000446054 | |
| Drug | quercetin | PLA2G7 GAD1 GAD2 UGT1A5 UGT1A4 UGT1A3 MTOR SAGE1 MAPK7 HSPA4 ALOX15 | 1.42e-05 | 482 | 105 | 11 | CID005280343 |
| Drug | NSC226080 | RPS6KA1 RPS6KB1 RPS6KB2 PRKD3 PTK2B EGFR MTOR GYS1 GYS2 PKN1 MAPK7 MAP2K5 HSPA4 VCAM1 | 1.44e-05 | 782 | 105 | 14 | CID000005040 |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 1.52e-05 | 314 | 105 | 9 | CID000003542 | |
| Drug | 4-nitrophenyl)imidazole | 1.53e-05 | 11 | 105 | 3 | CID000123155 | |
| Drug | AC1O5XMV | 1.53e-05 | 11 | 105 | 3 | CID006442661 | |
| Drug | UAB 30 | 1.58e-05 | 33 | 105 | 4 | ctd:C112106 | |
| Drug | 6-methylsalicylic acid | 1.58e-05 | 33 | 105 | 4 | CID000011279 | |
| Drug | methyl ethyl ketone | RPS6KA1 RPS6KB1 RPS6KB2 SRMS MAP3K4 PTK2B EGFR MTOR PLCG1 MAPK7 MAP2K5 VCAM1 | 1.70e-05 | 587 | 105 | 12 | CID000006569 |
| Drug | Ro 31-8220 | 1.81e-05 | 321 | 105 | 9 | CID000005083 | |
| Drug | 1h1q | 1.81e-05 | 70 | 105 | 5 | CID000001540 | |
| Drug | UDP-glucose | 1.93e-05 | 247 | 105 | 8 | CID000001166 | |
| Drug | LS-63783 | EPHX2 PLA2G7 DGKH PRKD3 ACSL4 PTK2B GYS1 GYS2 HRH1 PKN1 PLCG1 MAPK7 MAP2K5 ALOX15 | 1.96e-05 | 804 | 105 | 14 | CID000000231 |
| Drug | phorbol acetate myristate | RPS6KA1 RPS6KB1 RPS6KB2 SRMS DGKH PRKD3 PTK2B EGFR MTOR HRH1 PKN1 PLCG1 FGR MAPK7 PDGFC MAP2K5 HSPA4 VCAM1 ALOX15 | 1.96e-05 | 1399 | 105 | 19 | CID000004792 |
| Drug | N-OH-DABZ | 2.03e-05 | 12 | 105 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 2.03e-05 | 12 | 105 | 3 | CID000088735 | |
| Drug | quercetin 4'-O-glucopyranoside | 2.03e-05 | 12 | 105 | 3 | ctd:C110310 | |
| Drug | 2,4,6-TCB | 2.03e-05 | 12 | 105 | 3 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 2.03e-05 | 12 | 105 | 3 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 2.03e-05 | 12 | 105 | 3 | CID000276709 | |
| Drug | benz(a)anthracene-5,6-imine | 2.11e-05 | 2 | 105 | 2 | CID000051305 | |
| Drug | 3-Mercaptopropionic Acid | 2.11e-05 | 2 | 105 | 2 | ctd:D015097 | |
| Drug | quercetin 3-O-glucopyranoside | 2.11e-05 | 2 | 105 | 2 | ctd:C110309 | |
| Drug | AC1L26S0 | 2.11e-05 | 2 | 105 | 2 | CID000015863 | |
| Drug | 3-pyrazolidinone | 2.11e-05 | 2 | 105 | 2 | CID000151497 | |
| Drug | ethylphenylepoxygeranyl ether | 2.11e-05 | 2 | 105 | 2 | ctd:C100167 | |
| Drug | 3-fluoroglutamate | 2.11e-05 | 2 | 105 | 2 | CID003036462 | |
| Disease | retinol dehydrogenase 16 measurement | 1.06e-07 | 13 | 105 | 4 | EFO_0802007 | |
| Disease | angiopoietin-related protein 1 measurement | 4.46e-07 | 18 | 105 | 4 | EFO_0801382 | |
| Disease | lymphocyte count | GAD2 ACACA SPINK2 RPS6KA1 SPEF2 PTPN22 PLXNB2 CASZ1 MFSD2A PBRM1 EGFR NECTIN2 KLHL14 ADGRE1 PDGFC VCAM1 NOTCH2 DNMT3A RPAP2 | 9.13e-07 | 1464 | 105 | 19 | EFO_0004587 |
| Disease | X-11793--oxidized bilirubin measurement | 2.42e-06 | 8 | 105 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.42e-06 | 8 | 105 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 2.42e-06 | 8 | 105 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.42e-06 | 8 | 105 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 2.42e-06 | 8 | 105 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 2.42e-06 | 8 | 105 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.42e-06 | 8 | 105 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 2.42e-06 | 8 | 105 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.42e-06 | 8 | 105 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.42e-06 | 8 | 105 | 3 | EFO_0800766 | |
| Disease | X-11442 measurement | 3.62e-06 | 9 | 105 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 3.62e-06 | 9 | 105 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 3.62e-06 | 9 | 105 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 3.62e-06 | 9 | 105 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 3.62e-06 | 9 | 105 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 3.62e-06 | 9 | 105 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 3.62e-06 | 9 | 105 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 3.62e-06 | 9 | 105 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 3.62e-06 | 9 | 105 | 3 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 5.16e-06 | 10 | 105 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 5.16e-06 | 10 | 105 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 5.16e-06 | 10 | 105 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 5.16e-06 | 10 | 105 | 3 | EFO_0800867 | |
| Disease | histidine betaine (hercynine) measurement | 7.08e-06 | 11 | 105 | 3 | EFO_0800972 | |
| Disease | X-21796 measurement | 7.08e-06 | 11 | 105 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 7.08e-06 | 11 | 105 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 7.08e-06 | 11 | 105 | 3 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 9.41e-06 | 12 | 105 | 3 | EFO_0800079 | |
| Disease | biliverdin measurement | 9.41e-06 | 12 | 105 | 3 | EFO_0021033 | |
| Disease | spastic cerebral palsy (implicated_via_orthology) | 1.25e-05 | 2 | 105 | 2 | DOID:0050669 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.87e-05 | 17 | 105 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | glomerulonephritis (is_marker_for) | 4.07e-05 | 19 | 105 | 3 | DOID:2921 (is_marker_for) | |
| Disease | urate measurement, spine bone mineral density | 5.54e-05 | 58 | 105 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | tissue factor measurement | 5.56e-05 | 21 | 105 | 3 | EFO_0010623 | |
| Disease | Atherosclerosis | 5.93e-05 | 59 | 105 | 4 | C0004153 | |
| Disease | Atherogenesis | 5.93e-05 | 59 | 105 | 4 | C1563937 | |
| Disease | Lafora disease (implicated_via_orthology) | 7.49e-05 | 4 | 105 | 2 | DOID:3534 (implicated_via_orthology) | |
| Disease | Liver carcinoma | 8.49e-05 | 507 | 105 | 9 | C2239176 | |
| Disease | Sezary Syndrome | 1.20e-04 | 27 | 105 | 3 | C0036920 | |
| Disease | interstitial cystitis (is_marker_for) | 1.25e-04 | 5 | 105 | 2 | DOID:13949 (is_marker_for) | |
| Disease | xanthurenate measurement | 1.50e-04 | 29 | 105 | 3 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.66e-04 | 30 | 105 | 3 | EFO_0600017 | |
| Disease | Severe Congenital Microcephaly | 1.83e-04 | 31 | 105 | 3 | C3853041 | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.01e-04 | 32 | 105 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 2.06e-04 | 702 | 105 | 10 | C0009402 | |
| Disease | Microlissencephaly | 2.21e-04 | 33 | 105 | 3 | C1956147 | |
| Disease | hormone measurement | 2.35e-04 | 84 | 105 | 4 | EFO_0004730 | |
| Disease | cervical cancer | 2.42e-04 | 34 | 105 | 3 | C4048328 | |
| Disease | autoantibody measurement | 2.60e-04 | 7 | 105 | 2 | EFO_0004866 | |
| Disease | Uterine Cervical Neoplasm | 2.64e-04 | 35 | 105 | 3 | C0007873 | |
| Disease | Unipolar Depression | 3.36e-04 | 259 | 105 | 6 | C0041696 | |
| Disease | dementia (is_marker_for) | 3.46e-04 | 8 | 105 | 2 | DOID:1307 (is_marker_for) | |
| Disease | colon cancer (biomarker_via_orthology) | 3.65e-04 | 39 | 105 | 3 | DOID:219 (biomarker_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 3.93e-04 | 173 | 105 | 5 | C0023467 | |
| Disease | response to bronchodilator, FEV/FEC ratio | 4.12e-04 | 766 | 105 | 10 | EFO_0004713, GO_0097366 | |
| Disease | Mesothelioma | 4.23e-04 | 41 | 105 | 3 | C0025500 | |
| Disease | Cancer of Nasopharynx | 4.44e-04 | 9 | 105 | 2 | C0238301 | |
| Disease | alcohol dependence (implicated_via_orthology) | 4.44e-04 | 9 | 105 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | Nasopharyngeal Neoplasms | 4.44e-04 | 9 | 105 | 2 | C0027439 | |
| Disease | myeloid white cell count | GAD2 SPINK2 PTPN22 DGKH ABCA7 PTK2B OR10J5 VCAM1 NOTCH2 DNMT3A RPAP2 | 5.14e-04 | 937 | 105 | 11 | EFO_0007988 |
| Disease | Peripheral T-Cell Lymphoma | 5.54e-04 | 10 | 105 | 2 | C0079774 | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 5.57e-04 | 45 | 105 | 3 | DOID:3525 (implicated_via_orthology) | |
| Disease | gallstones | 6.11e-04 | 108 | 105 | 4 | EFO_0004210 | |
| Disease | cocaine use | 6.76e-04 | 11 | 105 | 2 | C3496069 | |
| Disease | pregnenetriol sulfate measurement | 6.76e-04 | 11 | 105 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 6.76e-04 | 11 | 105 | 2 | EFO_0600039 | |
| Disease | Glioblastoma Multiforme | 6.77e-04 | 111 | 105 | 4 | C1621958 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.77e-04 | 195 | 105 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | lipoprotein A measurement | 7.00e-04 | 112 | 105 | 4 | EFO_0006925 | |
| Disease | conotruncal heart malformations | 7.48e-04 | 114 | 105 | 4 | MONDO_0016581 | |
| Disease | eosinophil count | GAD2 SPINK2 SPEF2 POU2AF1 DGKH EMC8 APOH PTK2B PBRM1 NECTIN2 HSPA4 VCAM1 NOTCH2 ALOX15 | 8.07e-04 | 1488 | 105 | 14 | EFO_0004842 |
| Disease | hypertension | 8.21e-04 | 307 | 105 | 6 | EFO_0000537 | |
| Disease | Alzheimer disease, family history of Alzheimer’s disease | 8.78e-04 | 119 | 105 | 4 | EFO_0009268, MONDO_0004975 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 9.01e-04 | 53 | 105 | 3 | C1961099 | |
| Disease | diabetic retinopathy (is_marker_for) | 9.52e-04 | 54 | 105 | 3 | DOID:8947 (is_marker_for) | |
| Disease | Acute Cerebrovascular Accidents | 9.52e-04 | 54 | 105 | 3 | C0751956 | |
| Disease | pregnenetriol disulfate measurement | 9.54e-04 | 13 | 105 | 2 | EFO_0800587 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 9.54e-04 | 13 | 105 | 2 | C0238288 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.00e-03 | 55 | 105 | 3 | C0079744 | |
| Disease | bilirubin measurement | 1.04e-03 | 442 | 105 | 7 | EFO_0004570 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.05e-03 | 125 | 105 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.05e-03 | 125 | 105 | 4 | C1879321 | |
| Disease | Malformations of Cortical Development | 1.11e-03 | 14 | 105 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 1.11e-03 | 14 | 105 | 2 | C0431380 | |
| Disease | C-reactive protein measurement | GAD1 SEMA4D RPS6KA1 RPS6KB1 DGKH FNBP1L MLLT10 APOH OR10J5 UBP1 GYS2 NECTIN2 | 1.21e-03 | 1206 | 105 | 12 | EFO_0004458 |
| Disease | Malignant neoplasm of skin | 1.23e-03 | 59 | 105 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 1.23e-03 | 59 | 105 | 3 | C0037286 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.28e-03 | 15 | 105 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.28e-03 | 15 | 105 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.28e-03 | 15 | 105 | 2 | C0154091 | |
| Disease | Autosomal recessive primary microcephaly | 1.28e-03 | 15 | 105 | 2 | cv:C3711387 | |
| Disease | Cerebrovascular accident | 1.42e-03 | 62 | 105 | 3 | C0038454 | |
| Disease | Dermatitis | 1.46e-03 | 16 | 105 | 2 | C0011603 | |
| Disease | Polyposis, Adenomatous Intestinal | 1.46e-03 | 16 | 105 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 1.46e-03 | 16 | 105 | 2 | C2713443 | |
| Disease | Bladder Neoplasm | 1.60e-03 | 140 | 105 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.64e-03 | 141 | 105 | 4 | C0005684 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SHGVYESICNGVPMV | 376 | P35503 | |
| AEYPEGFEIHSMQSV | 236 | O60488 | |
| VFECLPQHAMFGNDT | 171 | P02749 | |
| CTEMERVFGFPVHYT | 861 | Q9Y6K1 | |
| VYMVQPQGCSDEEDH | 121 | Q86V15 | |
| SCTGNYIHPESMLFE | 86 | Q8WW27 | |
| CFMQEHVADPTAYGI | 536 | P54840 | |
| TIEHPFCMYDADQHI | 371 | Q9UDR5 | |
| GHVFAGQCYAEIEVM | 771 | Q13085 | |
| VGSMDAHPSRYCATV | 616 | Q9H9G7 | |
| EQAEDVFYIPSCMSG | 451 | Q9UPS8 | |
| KEAMTYHPNQVVEGC | 256 | Q96EU7 | |
| HLSMGYCPQSDAIFE | 1866 | Q8IZY2 | |
| LTVMAYDQFVAICHP | 116 | Q8NGA2 | |
| MDYSHQTSLVPCGQD | 1 | P50749 | |
| YLESQPHDSCFVEMQ | 471 | Q9Y2R2 | |
| FCIHYNIVMPQFTEA | 156 | Q9NRA1 | |
| YVIEPHSMEFAPCQV | 531 | Q8TEM1 | |
| GLCTSPAEHQYFMTE | 206 | Q13164 | |
| GYEPCVNEGMCVTYH | 31 | P0DPK3 | |
| GYEPCVNEGMCVTYH | 31 | Q04721 | |
| YEMVFDGKPQHTNVC | 491 | Q05329 | |
| VEMSNGEPGCHYFEQ | 1136 | Q86U86 | |
| HPFSDGVSALQIYCM | 606 | Q96AA8 | |
| YMHETITVNGCPEFR | 71 | O14910 | |
| VVCGTPTSHVYMFKN | 16 | Q5XG99 | |
| VDMGHSAYQVSVCAF | 201 | P34932 | |
| SEEPIYIVTEFMCHG | 326 | P09769 | |
| QCFSSCHMPLTGYEV | 526 | Q2TV78 | |
| DEPSCGSEVCVVMYH | 141 | Q6UX15 | |
| GSEVCVVMYHQPSAP | 146 | Q6UX15 | |
| VVTTPAFMCETALHY | 236 | A0A0B4J2D5 | |
| GFTMIGEHSIYCTVN | 256 | P08174 | |
| EMVFNGEPEHTNVCF | 501 | Q99259 | |
| QPMTVVGTDYVFHND | 1036 | O15031 | |
| ESMPSFQFCVYVHDQ | 1831 | Q9NYQ8 | |
| GEFSEPFVHFITQCM | 386 | Q13163 | |
| TCISNDFYSHMPVGE | 456 | Q32MH5 | |
| FNPHTYMICSSGVEK | 341 | Q96JK2 | |
| HTFCGTIEYMAPEIL | 251 | P23443 | |
| SNPHCFEIITDTMVY | 481 | O94806 | |
| PVMVAVGQHEEEYFS | 601 | P16050 | |
| GPIATVFTRECMSHY | 646 | Q96CW5 | |
| PMSTYLVCFAVHQFD | 281 | Q07075 | |
| PYEVAQFNVEHFSGM | 161 | Q86XP1 | |
| RHFNPVCGSDMSTYA | 46 | P20155 | |
| GPYSVGCTDLMFDHT | 61 | Q13093 | |
| PHKVITFTGCMVQFY | 86 | Q8N148 | |
| LFETMVTCFHVPYSA | 166 | Q8NA29 | |
| HEAVSCPYSADMYVQ | 111 | Q16633 | |
| TDQFATMCHGYTLPE | 206 | Q5SZD4 | |
| DEAYVMASVDNPHVC | 761 | P00533 | |
| GSMLASTPEFYQVCH | 381 | P61158 | |
| MVAHHIVENTYFCPV | 231 | Q05DH4 | |
| ESGYMHIQCTKPDTV | 296 | P07099 | |
| SCNPSDMSHGYVTVK | 231 | P34913 | |
| TIMPYNSAHHCVVEV | 356 | Q9P2G3 | |
| YHVCQGSMPTEEDLR | 736 | Q6AI39 | |
| SIEPVHYCMNEIKTG | 356 | Q5T0N5 | |
| HYVMCAQFHPTEDLV | 136 | P53621 | |
| MCVAFSSYEEHPIFV | 66 | Q96PG1 | |
| VVTTPAFMCETALHY | 236 | P0DPI2 | |
| HAARTVCYSPEGDMV | 1736 | Q05BV3 | |
| KFTMDCVAPTIHVYE | 131 | O43402 | |
| YCFPLDIVHMQAAAE | 301 | P35367 | |
| HPQMTVGEVQDKYEC | 106 | Q14289 | |
| CFMEEHIADPSAYGI | 536 | P13807 | |
| AGAMTFHYIIEQGVC | 56 | O75396 | |
| VASQGFPSTCGHYAM | 171 | O95487 | |
| FAGCMSSVQYNHIAP | 1161 | Q8WYK1 | |
| TAGSHFMASPQCVGY | 256 | Q9H488 | |
| TVVDHFFCDIYPVMK | 171 | Q8NHC4 | |
| EYTCMIPRDTHDGAF | 1531 | P42345 | |
| VCDTPKSYDNVMHVG | 1321 | Q9Y6R4 | |
| AATMQFVPGHFSCDV | 2026 | Q5T011 | |
| MLLYFACHPDTVEGV | 1631 | Q9C093 | |
| TMNPVSFGNEHSYLC | 81 | P19320 | |
| MPEHYVEGSTVNCVL | 71 | Q86VP1 | |
| FPDNVEHCETVFGML | 1816 | A6NHR9 | |
| GYVNGTMPDITVCAH | 236 | P12259 | |
| THTFCGTIEYMAPEI | 226 | Q9UBS0 | |
| FPLCGHMVSDEYEQL | 46 | P27635 | |
| QTPEHVCFVMEYSAG | 686 | Q16512 | |
| CPFDPAHSYTSVMVD | 156 | Q92854 | |
| MHAFCVGQYLEPDQE | 1 | Q9BVR0 | |
| LHEVFTYGQCPYEGM | 416 | Q9H3Y6 | |
| GTMLPVFCVVEHYEN | 71 | Q01826 | |
| LEIATHMPGSYCVQV | 406 | Q8WZ75 | |
| HMPGSYCVQVAAVTG | 411 | Q8WZ75 | |
| VCPEHSDCVNSMGSY | 141 | Q14246 | |
| EISMQYRHDGACPTT | 541 | P55197 | |
| APCEIMYSVIGHHET | 271 | O43529 | |
| SSYQAVMPHFVCLAD | 326 | Q7Z7L8 | |
| SGRIECHYEPMESSF | 241 | Q5SXH7 | |
| MYAAVEHGPVLCSDS | 1 | Q9NRJ4 | |
| VEHSEHTQYPCMVQG | 1541 | Q13129 | |
| MECGRFITPAHYSDV | 76 | Q8IXW5 | |
| GLYSTVPHNVCEEKM | 291 | Q9NXZ1 | |
| PQENVCHLFAEYDMV | 681 | Q8IZW8 | |
| CHLFAEYDMVQPASQ | 686 | Q8IZW8 | |
| SHGVYESICNGVPMV | 376 | P35504 | |
| PDQSHCFVILYGMEF | 101 | P19174 | |
| EAYESHEGMCPQESV | 151 | Q9BUZ4 | |
| AQGVHAPSTCSYMEA | 1201 | O43379 | |
| DGETEHPPFQYVMCA | 56 | Q9NZI7 | |
| HEMVAEPPVVCSYFA | 36 | Q9P255 | |
| YHEEGTQECAMVNPI | 1621 | Q6ZT12 | |
| EFTGFVDMCVQHIPS | 426 | Q15029 | |
| DTFSTTPMGVHDCGY | 261 | Q5TAA0 | |
| YSFGTAAHPMEQVED | 431 | Q8NFA0 | |
| SHGVYESICNGVPMV | 376 | P22310 | |
| SFCGTVEYMAPEVVN | 221 | Q15418 | |
| CIFYGMIADGTHTNP | 261 | Q9Y303 | |
| DAGASCTEQEMPRYH | 441 | Q92692 |